R
Reata Pharmaceuticals Inc
F:2R3
Reata Pharmaceuticals Inc
F:2R3
Price:
161
EUR
Market Closed
Market Cap:
€6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Reata Pharmaceuticals Inc
F:2R3
|
US |
|
Kinross Gold Corp
TSX:K
|
CA |
|
Telefast Indonesia Tbk PT
IDX:TFAS
|
ID |
|
Science Applications International Corp
NASDAQ:SAIC
|
US |
|
S&T Bancorp Inc
NASDAQ:STBA
|
US |
|
T
|
Tiande Chemical Holdings Ltd
HKEX:609
|
HK |
|
Kian Shen Corp
TWSE:1525
|
TW |
|
Dareway Software Co Ltd
SSE:688579
|
CN |
|
NZME Ltd
NZX:NZM
|
NZ |
|
Essential Energy Services Ltd
TSX:ESN
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 2R3.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2R3
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
2R3 Competitors Multiples
Reata Pharmaceuticals Inc Competitors
Reata Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
R
|
Reata Pharmaceuticals Inc
F:2R3
|
6.1B EUR | 305.6 | -81.9 | -20.3 | -20.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
